This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.90% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Implied Volatility Surging for Accendra Health Stock Options
by Zacks Equity Research
Investors need to pay close attention to ACH stock based on the movements in the options market lately.
ACHNegative Net Change
medical medical-devices
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
by Zacks Equity Research
AVTR looks worth holding as its broad portfolio, strategic deals and cost savings offset Lab Solutions' weakness for now with AI tools and strong cash flow.
BSXNegative Net Change ISRGNegative Net Change MEDPNegative Net Change AVTRPositive Net Change
medical medical-devices
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?
by Zacks Equity Research
BSX is seeing solid international growth, MedSurg market-share gains and surging WATCHMAN sales, though macro and competition remain risks.
BSXNegative Net Change DGXNegative Net Change PAHCPositive Net Change BTSGNegative Net Change
medical medical-devices
Here's Why You Should Retain Cencora Stock in Your Portfolio Now
by Zacks Equity Research
Cencora's strength in U.S. Healthcare Solutions, along with rising specialty drug demand and biosimilar adoption, supports growth, though competitive pressures and international weakness remain headwinds.
BSXNegative Net Change ISRGNegative Net Change CORNegative Net Change MEDPNegative Net Change
medical medical-devices
Implied Volatility Surging for Guardian Pharmacy Services Stock Options
by Zacks Equity Research
Investors need to pay close attention to Guardian Pharmacy Services stock based on the movements in the options market lately.
GRDNNegative Net Change
medical medical-devices
4 PEG-Based GARP Picks for Navigating Early-2026 Market Uncertainty
by Urmimala Biswas
PAHC and others highlight how PEG-based GARP picks blend value and growth as markets hit 2026 highs amid rate uncertainty and valuation sensitivity.
CMCNegative Net Change FOXNegative Net Change PAHCPositive Net Change ATGENegative Net Change
basic-materials consumer-discretionary medical medical-devices
BFLY to Extend 3D Imaging Capabilities to Butterfly Garden Developers
by Zacks Equity Research
Butterfly Network targets a 2026 Beam Steering API, opening core imaging to developers and enabling AI tools in Butterfly Garden.
VCYTPositive Net Change KRMDNegative Net Change SDGRNegative Net Change BFLYNegative Net Change
medical medical-devices
ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves
by Zacks Equity Research
AngioDynamics reports flat Q2 earnings while revenue increase 8.8% and gross margin expands 170 bps on stronger Med Tech performance.
BSXNegative Net Change ANGONegative Net Change ISRGNegative Net Change MEDPNegative Net Change
earnings medical medical-devices
Here's Why You Should Add PacBio Stock to Your Portfolio
by Zacks Equity Research
PACB is gaining from product development and strong Q3 results, with Revio and Vega driving growth, though longer purchasing cycles remain a risk.
BSXNegative Net Change ISRGNegative Net Change PACBNegative Net Change MEDPNegative Net Change
medical medical-devices
MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
MRKRPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now?
by Indrajit Bandyopadhyay
ISRG trades just 4% below its record high after a 32% surge over the past three months, driven by strong procedure growth, rising utilization, and early traction for the da Vinci 5 system.
MDTNegative Net Change ISRGNegative Net Change PRCTNegative Net Change
medical medical-devices
5 Highly Efficient Stocks That Stand Out on Key Profitability Ratios
by Santanu Roy
United Natural Foods leads a screen of five efficient stocks that beat peers on key ratios, highlighting names investors may consider for stronger returns.
ULTANegative Net Change ELMDNegative Net Change UNFINegative Net Change NRIMNegative Net Change LSPDNegative Net Change
computers consumer-staples finance internet medical-devices
IDEXX Stock Up 64.7% in a Year: What's Driving the Growth?
by Zacks Equity Research
IDXX shares surge 64.7% in a year as CAG Diagnostics momentum, strong retention and expanding software adoption fuel growth across regions.
DGXNegative Net Change IDXXPositive Net Change PAHCPositive Net Change BTSGNegative Net Change
medical medical-devices
CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection
by Zacks Equity Research
Ceribell wins FDA Breakthrough status for its AI-driven EEG solution to detect and monitor LVO strokes in hospitals, boosting credibility and growth outlook.
BSXNegative Net Change ISRGNegative Net Change MEDPNegative Net Change CBLLNegative Net Change
medical medical-devices
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device
by Zacks Equity Research
OSUR files FDA applications seeking approval for two at-home STI tests, advancing decentralized diagnostics; shares gain 3.8% as it targets long-term growth.
BSXNegative Net Change OSURNegative Net Change ATRCNegative Net Change SMTINegative Net Change
medical medical-devices
Hologic's Breast Health Unit Stays In Focus in 2026: What Lies Ahead?
by Moumi Mondal
HOLX's Breast Health unit is back in focus as a proposed Blackstone-TPG deal adds a $76 cash offer and CVR to 2026-27 revenue goals.
DGXNegative Net Change HOLXNegative Net Change GEHCNegative Net Change
medical medical-devices
Should Labcorp Stock Stay in Your Portfolio Right Now?
by Zacks Equity Research
LH's growth bets in specialty testing and acquisitions support its outlook, but macro pressures and currency headwinds remain key risks.
LHPositive Net Change DGXNegative Net Change PAHCPositive Net Change BTSGNegative Net Change
medical medical-devices
OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth
by Zacks Equity Research
OPK leans on RAYALDEE momentum and strategic partnerships as pipeline trials advance, though reliance on its lone U.S. drug adds risk.
BSXNegative Net Change ISRGNegative Net Change OPKNo Net Change MEDPNegative Net Change
medical medical-devices
McKesson Builds Earnings Momentum on Specialty and Automation
by Zacks Equity Research
McKesson posts a strong fiscal second quarter, lifts full-year EPS outlook, and shows how specialty growth and automation are reshaping its earnings power.
CAHNegative Net Change MCKNegative Net Change CVSNegative Net Change CORNegative Net Change
medical medical-devices
Here's Why You Should Retain Masimo Stock in Your Portfolio Now
by Zacks Equity Research
MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks linger.
MASIPositive Net Change VCYTPositive Net Change TCMDNegative Net Change AORTPositive Net Change
medical medical-devices
Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization
by Debanjana Dey
HIMS deepens its AI and data strategy with personalized care tools, biomarker tracking, and smarter treatment matching.
HIMSPositive Net Change DOCSPositive Net Change TEMPositive Net Change
medical medical-devices
Watch 5 AI-Powered Medical Stocks for a Strong Portfolio in 2026
by Nalak Das
LLY, MDT, ISRG, REGN and JNJ are five defensive medical stocks using AI to drive growth, diagnostics and innovation into 2026.
REGNNegative Net Change JNJNegative Net Change LLYPositive Net Change MDTNegative Net Change ISRGNegative Net Change
medical medical-devices pharmaceuticals
Hologic Trading Near 52-Week High: How Should You Play the Stock?
by Moumi Mondal
HOLX nears its 52-week high on diagnostics growth and AI adoption, while tariffs and challenges in China continue to pose risks.
ABTNegative Net Change HOLXNegative Net Change COOPositive Net Change
medical medical-devices
CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus
by Zacks Equity Research
CV seeks FDA clearance to add AI-based reading to CapsoCam Plus to boost diagnostic accuracy and streamline reviews.
OMCLNegative Net Change CVPositive Net Change SDGRNegative Net Change CCLDPositive Net Change
medical medical-devices
INBS Stock Surges 132.4% on New Manufacturing Partnership
by Zacks Equity Research
Intelligent Bio Solutions' stock jumps after a new manufacturing partnership aimed at cutting costs, boosting margins and scaling production ahead of U.S. expansion.
BSXNegative Net Change ISRGNegative Net Change MEDPNegative Net Change INBSPositive Net Change
medical medical-devices